Impact of statins on depression and suicidality: a systematic review
Statins have been proposed for repurposing in depression, but previous meta-analyses reported heterogeneous results and seldom addressed suicidality. We systematically reviewed the association of statin treatment with the risk of depression, depressive symptom severity and suicidality. We searched 3 databases (Embase, PsycINFO and PubMed) up to 31 March 2026 for observational and interventional studies in predominantly adult populations, published in English or French. Risk of bias and methodological quality were assessed with RoB 2 for randomised controlled trials (RCTs) and the NIH/NHLBI tools for observational studies. Results were synthesised by design, outcome and sample size. Sixty studies were included (9 cross-sectional, 38 longitudinal and 13 RCTs; 20 to over 4.6 million participants), 55 assessing depression and 11 suicidality. Observational associations were heterogeneous: generally modest in large general-population studies, mainly inverse in disease-specific populations, but discordant after stroke and traumatic brain injury. Larger antidepressant effects of adjunctive statins were reported in small single-centre RCTs. In contrast, the two largest trials in major depressive disorder, both at low risk of bias, yielded estimates close to zero. No consistent association with suicidality was observed, and no trial showed a significant worsening of mood. This systematic review updates and extends previous meta-analyses on statins. Observational results were heterogeneous. Lower suicide mortality was observed in two cohorts, but the largest study found no association with suicidal behaviour. Larger antidepressant effects were confined to small single-centre trials. Current evidence therefore does not support prescribing statins for antidepressant or suicide-preventive purposes.
Authors
- Nicolas Hoertel (ORCID: https://orcid.org/0000-0002-7890-1349)
- Louis Colin
- Ariel Frajerman (ORCID: https://orcid.org/0000-0002-4441-3873)
- Tarsis Carvalo Ouro Vitorino Silva1
Institutions
- Université Paris Cité (FR)
- Université Paris-Saclay (FR)
- FHU Neurovasc (FR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11767079/v1
- Primary Topic
- Treatment of Major Depression
- Type
- preprint